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ABSTRACT 
 
Background: Asbestos mining operations have left South Africa with a 
legacy of asbestos contamination. Hence asbestos-related diseases 
continue to be a problem. Currently there are no South African studies that 
have determined the relationship between asbestos type, fibre sizes or 
asbestos burden and the development of histological subtypes of 
mesothelioma.  
Objectives: The aim of this study was to describe the demographics and 
asbestos fibre burden of individuals with mesothelioma. The associations 
between the asbestos type, fibre sizes and asbestos burden and the 
histological subtype of mesothelioma were also determined. 
Methods: The records of all deceased miners, ex-miners, Asbestos Relief 
Trust and Kgalagadi Relief Trust compensation Trust claimants in the 
PATHAUT database who were histologically diagnosed with mesothelioma 
for the period Jan 2006 – Dec 2016 (11 years) were reviewed. 
Results: In all, 270 cases of mesothelioma were reported from 2006 to 
2016. The mean age of the mesothelioma cases was 64.0± 10.8 years. 
About 89.3% were occupationally exposed to asbestos while 10.7% were 
environmentally exposed. The prevalence of the histological types of 
mesothelioma was 64.4%, 23.3%, 12.2% for epithelioid, biphasic and 
sarcomatous subtypes respectively. Our study demonstrated that on 
average, individuals with the sarcomatous subtype appeared to be about 
five years older at diagnosis than individuals diagnosed with the other two 
histological subtypes. Asbestos fibre analysis showed crocidolite was 
present in most of the lungs (n=155; 94.5%) that contained asbestos 
fibres, with 85.4% (n=140) of mesothelioma cases having only crocidolite 
in their lungs. The epithelioid subtype was a major histological subtype 
among both occupational (63.9%) and environmental (69.0%) cases. 
Conclusion: No relationship was established between the subtypes of 
mesothelioma and the asbestos types, fibre sizes or asbestos burden. 
Keywords: Histological subtype, PATHAUT, ART, KRT, South Africa  
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CHAPTER ONE – INTRODUCTION 
 
1.1 Background 
 
South Africa is a mineral-rich country and its economy was underpinned 
by mining. Asbestos was one mineral that was mined for more than 100 
years (Murray et al., 2015). South Africa was the world’s third-largest 
producer of asbestos, with production peaking in 1977 (Virta, 2006). 
Uniquely, three different types of asbestos, namely amosite, crocidolite 
and chrysotile were mined on a large commercial scale (Hart, 1988). Most 
of South Africa’s asbestos production was exported, but some was used to 
manufacture goods within the country (Harrington & McGlashan 1988). 
 
Asbestos has useful properties and confers strength and durability to 
manufactured products in which it is incorporated to (Hart, 1988). 
However, asbestos is associated with adverse health effects. Inhalation of 
asbestos fibres causes diffuse pleural thickening, pleural plaques, 
asbestosis, lung cancer and malignant mesothelioma of the pleura 
(mesothelioma) (Churg & Green 1998). The association between 
crocidolite asbestos and mesothelioma was established by Wagner and 
colleagues in 1960 (Wagner et al.,1960). Mesothelioma is an invariably 
fatal tumour which usually occurs about 20 to 40 years after exposure to 
asbestos (Bianchi & Bianchi, 2007). The diagnosis is confirmed 
histologically and classified under three main histological types of 
mesothelioma namely epithelioid, sarcomatous and a mixed or biphasic 
type with both epithelioid and sarcomatous elements (Franklin et al., 
2016). Current treatment modalities are ineffective (Orenstein & Schenker, 
2000). 
 
Because of activities such as mining, milling and transporting of asbestos, 
there is widespread contamination of the environment. In addition, there 
are large amounts of asbestos in manufactured items in the built 
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environment such as asbestos cement roofs (Phillips et al., 2016). This 
legacy of asbestos in the South African environment means that there is a 
potential for exposure and disease for many years to come. 
The large-scale mining of three types of asbestos along with the detailed 
data captured at the NIOH in the PATHAUT database presents a unique 
opportunity to study mesothelioma in South Africa. This also enables us to 
study asbestos lung fibre burden, mesothelioma subtypes and any 
relationships between asbestos lung fibre burden and the development of 
the mesothelioma subtypes. 
 
 
1.1.1 Asbestos in South Africa  
 
Asbestos is a generic name given to a group of rock-forming, fibrous, 
silicate minerals (Hart, 1988). The asbestos group is divided into an 
amphibole and a serpentine class as shown in Table 1.1. The six 
members of the two groups differ in their structure, chemical composition 
and biological effect (Roggli, 1990). The sole member of the serpentine 
class is chrysotile, also known as white asbestos, which is a hydrated 
magnesium silicate (Phillips et al., 2012) displayed in Figure 1.1a. 
Chrysotile consists of curved fibres and does not contain any iron. The 
amphiboles have straight fibres and contain iron with combinations of 
other cations. The two types of amphiboles that were mined in South 
Africa are amosite, also known as grunerite or brown asbestos, and 
crocidolite also known as riebeckite or blue asbestos (Roggli, 1990) 
displayed in Figure 1.1b and c. Crocidolite contains sodium, magnesium 
and iron, whereas amosite contains magnesium and iron (Phillips et al., 
2012). The other three amphiboles are tremolite, actinolite and 
anthophyllite but these were not mined on a large commercial scale in 
South Africa (Phillips et al., 2012). The asbestos types are structurally and 
chemically different and may be expected to trigger different health effects.  
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Table 1.1: Asbestos chemical structures and common uses (adapted 
from Hart, 1988). 
 
Group Type Chemical structure Common uses 
Serpentine Chrysotile Mg6 [(OH)4 Si2O5]2 
Asbestos textiles, friction 
linings, asbestos cement and 
insulation products. 
Amphibole Crocidolite Na2Fe5[(OH)Si4O11] 
Boiler lagging, acid-resistant 
packages, gaskets and 
asbestos cement products. 
Amphibole Amosite MgFe6[(OH)Si4O11]2 
Felted insulation, covering for 
marine turbines, jet engines 
and asbestos cement products. 
 
 
It is estimated that, worldwide, asbestos was used in the manufacture of 
more than 3000 products (Liddell 1997). These products include brake 
linings, roofing sheets, floor tiles, ropes, insulation materials, prefabricated 
wall sections, pipes and heat resistant clothing. Asbestos products were 
used in a broad range of industries such as construction, transport and the 
electricity, gas and water supply sector (Milne et al., 2013). The demand 
for all types of asbestos was due to its unique properties. These properties 
include durability, flexibility, high tensile strength, incombustibility and 
resistance to heat and various chemical solutions (Hart, 1988). 
 
 
 
 
 
 
 
 
Figure 1.1: The three principal types of asbestos, from the left a) chrysotile, b) 
crocidolite and c) amosite. Photographs courtesy of the National Institute for 
Occupational Health.  
 
Chrysotile Amosite 
 
Crocidolite 
a) b) c) 
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1.1.2 History of asbestos mining in South Africa 
 
South Africa is a uniquely mineral-rich country and its economy was built 
on the mining of minerals (Phillips et al., 2012). Asbestos was one of these 
minerals and South Africa was the only country to mine all three 
commercial types of asbestos (Hart 1988).  
 
Crocidolite asbestos mining operations began in 1893 and in the period 
from 1910 to 1920 several small operations were started by farm owners 
who obtained mining rights. Over time these small mines were bought by 
large companies such as the Griqualand Exploration and Finance 
Company Limited (GEFCO) (van Zyl, 2017). In 1920 to 1930, the 
exportation of asbestos increased (Felix et al., 1994) from 7 567 to 10 928 
tons (Virta, 2006). In 1977, South Africa was the world’s third-largest 
producer of asbestos (Phillips et al., 2012) behind Russia and Canada 
(Virta, 2005). South African asbestos was milled locally, and more than 
75% of the production was exported after 1960 (Virta, 2006). The fibre 
was first exported to Europe, North America, South America and later to 
other parts of Africa, the Middle East, Far East and Oceania (Hart, 1988; 
Virta, 2006). In the 1970s, some 350 000 tons of asbestos were exported 
annually (Kielkowski et al., 2011). 
 
Awareness concerning the adverse health effects of asbestos also 
increased in the 1970s and countries started imposing restrictions on the 
use of asbestos (Kazan-Allen, 2019; Virta, 2006). By 1977, South African 
crocidolite production peaked and production surpassed demand (Virta, 
2006). This affected the profitability of asbestos mining (Phillips et al., 
2016). As the demand for asbestos further declined, mines began to close 
(Nelson & teWater Naude 2016). The last asbestos mine in South Africa, a 
chrysotile mine at Msauli, in Mpumalanga Province, closed in 2002 
(McCulloch, 2003) and the asbestos cement manufacturer, Everite, used 
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its last bag of asbestos in its manufacturing process at the end of 2002 
(Gibson, 2019). 
 
1.1.2.1 Chrysotile  
 
In 1905, chrysotile deposits were discovered in the Barberton area in 
Mpumalanga, close to the Swaziland border (Felix et al., 1994). Later in 
1937, chrysotile was discovered in the Msauli River valley area, near 
Barberton, in what was the Eastern Transvaal, and which is now 
Mpumalanga Province. The Msauli mine was the most productive South 
African chrysotile mine, with an annual production capacity of 110 000 
tons and a workforce of approximately 1 650 employees (Felix et al., 
1994). Production of chrysotile peaked in 1989 at about 115 000 tons 
(Virta, 2006). Chrysotile was also mined in other provinces including 
Limpopo and Kwazulu-Natal (Phillips et al., 2012).  
 
 
1.1.2.2 Crocidolite 
 
Crocidolite was discovered in the 1800s in the town of Prieska in the 
Northern Cape Province (Felix et al., 1994). The crocidolite belt in the 
Northern Cape Province extends from Prieska, past Griquatown and 
Kuruman, to Pomfret, an approximate distance of 450 km (Hart, 1988). 
The mining of Cape Crocidolite started in 1893 in Prieska and escalated in 
the Second World War (Felix et al., 1994). The production of crocidolite 
peaked in 1977 at 200 000 tons and dropped to 12 000 tons in 1992 (Hart, 
1988; Felix et al., 1994). The crocidolite mines employed between 12 000 
and 14 000 workers and mining ended in 1997 (Virta, 2006).  
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1.1.2.3 Amosite 
 
The name amosite is an acronym for “asbestos mines of South Africa”. 
Amosite was first discovered in 1907 in the Lydenburg fields in 
Mpumalanga, on the farm Penge, near Burgersfort (Felix et al., 1994; van 
Zyl, 2017). Commercial mining started in 1914. Amosite deposits were 
also found in the Pietersburg asbestos fields where seams of Transvaal 
crocidolite were reported to overlap with amosite (Felix et al., 1994; 
Phillips et al., 2012). The British Navy together with other companies used 
asbestos to manufacture amosite insulation, fireproof clothing and brake 
pads for armoured vehicles (McCulloch, 2003). Amosite production 
peaked in 1973 at 106 000 tons (Hart, 1988) and with 7 000 employees. 
South Africa was the only producer of amosite (Webster, 1973). Penge 
was the only amosite-asbestos mine in the world (Hart, 1988). The Penge 
mine closed in 1992 (Felix et al., 1994).  
 
 
1.1.3 Asbestos contamination  
 
Asbestos mining operations in South Africa have left a legacy of 
environmental contamination. This contamination is still present around 
mines and tailings dump. It is also present around roads and railways that 
were used to transport asbestos across the country (Braun & Kisting 2006; 
Milne et al., 2013). The responsibility for ensuring contaminated areas, 
where mines operated, are rehabilitated, lies with the Department of 
Minerals and Energy. Other contaminated areas outside of the mining 
sites fall under the governance of the Department of Environmental Affairs 
and Tourism. In addition to mining and environment contamination, South 
Africa has a legacy of durable asbestos-containing products in the 
environment (Phillips et al., 2016) mainly in buildings in the form of cement 
roofs, vinyl floor tiles and cement materials (Vorster et al., 2018). The 
asbestos regulations make provision for the safe disposal of asbestos 
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products at specifically designated asbestos disposal sites (Department of 
Labour, 2002). Examples of these disposal sites in South Africa include 
Holfontein and Chloorkop in Gauteng. Some countries have recognised 
the need for spatial planning of designated asbestos waste sites in 
eradicating asbestos-containing products from the environment (Wilk et 
al., 2017). 
 
1.1.3.1 Rehabilitation of contaminated areas 
 
Some of the asbestos contaminated areas have been rehabilitated such 
as the Prieska mill site, part of Penge, Mafefe and Heuningvlei 
(Liebenberg-Weyers, 2010). The Department of Mineral Resources 
appointed Mintek, South Africa's national mineral research organisation, to 
rehabilitate asbestos mines (Cornelissen et al., 2019). Rehabilitation is a 
complex and expensive process and many asbestos contaminated areas 
remain unrehabilitated in South Africa (Ndlovu et al., 2013). A 
rehabilitation prioritization index (RPI) for South Africa was developed in 
2007 (Liebenberg et al.,2012). This index was developed to provide a 
scientifically-based sequence, from high risk to low risk, in which asbestos 
mines should be rehabilitated. The RPI was later implemented by the 
South African Department of Minerals and Energy (Van Rensburg, 2009). 
One hundred and forty-five asbestos contaminated areas were identified 
as a priority to rehabilitate, of which in 2009, 84 still needed to be 
rehabilitated (Van Rensburg, 2009). Data on the number of asbestos 
mines that still need to be rehabilitated seems to be inconsistent. 
Cornelissen and colleagues (2019) reported 40 of 249 asbestos mines 
have been rehabilitated. 
 
Unrehabilitated asbestos contaminated areas continue to pose health risks 
to nearby communities. Especially communities in the Northern Cape, 
Limpopo and Mpumalanga provinces, where asbestos was mined. 
Although environmental exposure to asbestos fibres is at a lower level 
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than occupational exposures, it has been shown to cause asbestos-
related diseases including mesothelioma (Orenstein & Schenker, 2000).  
 
 
1.1.4 Asbestos exposure in South Africa 
 
Asbestos fibres that enter the lungs through inhalation may cause 
asbestos-related diseases (Meintjes et al., 2008). These fibres which enter 
the lung are known as respirable fibres and there are many sources of 
exposures to such fibres. Although asbestos exposures no longer occur in 
asbestos mines, mills and the manufacturing of asbestos products, 
asbestos exposures still occur occupationally and environmentally. 
Asbestos fibres in contaminated areas still pose a health risk to nearby 
communities (Braun & Kisting 2006). Contaminated areas include 
unrehabilitated or partially rehabilitated asbestos dumps, dried riverbeds, 
roads and railways where asbestos spillage took place (Braun & Kisting 
2006). Other exposures include asbestos fibres liberated from asbestos 
products when the products age or are not kept in good condition (Vorster 
et al., 2018) Fibres can also be released during maintenance on or 
demolition of asbestos building materials (Phillips et al., 2016). 
 
 
1.1.4.1 Occupational exposure 
 
In South Africa, there are large populations with previous occupational 
exposure, the majority being asbestos miners, millers and workers 
involved in the manufacturing of asbestos products. Boilermakers, 
plumbers, shipyard workers, construction workers, metal smelter workers 
and mechanics may still be exposed to asbestos (Davies et al., 1987; 
Martin 2001; Rice & Heineman 2003 and Roggli et al., 2002). There are 
also some unexpected high-risk occupations where asbestos exposure 
may occur, such as farmworkers, policemen and teachers (Rees et al., 
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1999). In certain occupations, mesothelioma cases that had substantial 
asbestos exposure, such as the manufacturing of asbestos building 
materials and the installation of asbestos insulation, have declined due to 
the asbestos ban, whereas we continue to see mesothelioma cases in 
construction workers (Gilham et al.,2016; Rudd et al., 2010; Vimercati et 
al., 2019). This may be due to the exposure of workers while repairing, 
renovating or demolishing materials that contain asbestos. 
 
 
1.1.4.2 Non-occupational exposure 
 
Aside from occupational exposure, there are other non-occupational 
situations where persons can be exposed. Non-occupational exposures 
may be grouped into domestic, neighbourhood and true environmental 
exposure (Orenstein & Schenker, 2000). Domestic exposure can also be 
referred to as para-occupational or familial exposure (Orenstein & 
Schenker, 2000). This can occur when asbestos workers carry asbestos 
fibres home on their working clothes which usually affects their family 
members (Ndlovu et al., 2013). In some instances, asbestos was also 
used in hobby or leisure activities (Marinaccio et al., 2015). 
Neighbourhood exposure, also referred to as environmental exposure, 
affects residents living close to mine tailings or other asbestos 
contaminated areas (Ndlovu et al., 2013). True environmental exposure 
arises from naturally occurring asbestos contaminated soil (Ndlovu et al., 
2013).  
 
 
1.1.5 Asbestos-related diseases 
 
The inhalation of asbestos fibres can cause specific asbestos-related 
diseases and these are pleural plaques, diffuse pleural thickening, 
asbestosis, lung cancer and malignant pleural mesothelioma (Ndlovu et 
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al., 2013). Pleural plaques are thickened fibrous areas of the pleural due 
to collagen deposition in response to injury to the pleural membrane that 
lines the lungs (Mutsaers et al., 2004). Over time the collagen may calcify. 
Pleural plaques may be markers of asbestos exposure and are associated 
with lower levels of asbestos exposure (Chauhan, 2005; O'Reilly et al., 
2007). Diffuse pleural thickening is a result of scar tissue thickening the 
pleura or lining of the lungs (Wolff et al., 2015). Asbestosis, a fibrosis of 
the parenchyma of the lung, is typically associated with high levels of 
asbestos exposure (Ndlovu et al., 2013). Lung cancer is also associated 
with high levels of asbestos exposure but cannot be distinguished 
histologically from lung cancer caused by other factors such as cigarette 
smoking (Chauhan, 2005). While lung cancer has multiple other causes, 
mesothelioma appears to be a fibre specific tumour (Rees et al., 1999). 
South Africa is amongst 10 countries with the highest burden of 
mesothelioma in the world (Murray et al., 2015). Mesothelioma continues 
to be a legacy of asbestos mining in South Africa as asbestos was mined 
for more than 100 years and due to the high intensities of exposure 
(Murray et al., 2015). 
 
 
1.1.5.1 Malignant mesothelioma 
 
Malignant pleural mesothelioma is a relatively rare tumour compared to 
lung cancer (Perez-Guzman et al., 2016). The tumour arises from the 
pleura which covers the lung and chest wall (Chauhan, 2005). 
Mesothelioma is almost always associated with exposure to asbestos 
fibres. The link between exposure to crocidolite asbestos fibres and the 
development of mesothelioma was made in 1960 in South Africa by 
Wagner, Sleggs and Marchand (Wagner et al., 1960).  
 
Mesothelioma does not develop immediately after exposure but has a long 
latency period typically reported as 20 to 40 years (Bianchi and Bianchi, 
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2007). In a review of 21 articles, documenting a total of 1105 histologically 
confirmed cases of mesothelioma in occupationally exposed workers 
(Lanphear & Buchner, 1992), it was reported that there was a median 
latency period of 32 years after initial exposure until death, with a range of 
13 to 70 years. Differences in reported latency periods were addressed by 
Bianchi and Bianchi (2007). The authors highlighted that the intensity of 
exposure to asbestos has to be taken into account as a relationship 
between the intensity of exposure and the length of the latency period 
exists (Bianchi and Bianchi, 2007). It has been suggested that a minimum 
of 10 years from first exposure to asbestos is required to attribute the 
development of mesothelioma to asbestos exposure (Wolff et al., 2015). 
Because of the long latency period of this type of tumour ex-mine workers 
and individuals that were exposed to asbestos many years ago continue to 
present with mesothelioma. 
 
Patients diagnosed with mesothelioma have a very poor prognosis 
(Ndlovu et al., 2013). There are no effective clinical treatment options and 
patients usually die within 18 months from the time of diagnosis (Orenstein 
& Schenker, 2000). Some studies have reported even lower median 
survival periods of 9.4 months (Neragi-Miandoab et al., 2008) and 10.5 
months (Ceresoli et al.,2001). 
 
Patients with mesothelioma typically present with chest pains, shortness of 
breath and a cough (Wagner et al., 1960). Mesothelioma rarely 
metastasises but is locally aggressive and grows rapidly around the lung, 
encasing the lung and compressing viable lung parenchyma (Campbell, 
1950; Tertemiz et al., 2014). The diagnosis is confirmed histologically 
(Røe & Stella, 2015) and a panel of immunohistochemistry stains are 
useful for making an accurate diagnosis (Geltner et al., 2016; Husain et 
al., 2018).  
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Immunohistochemical stains assist with differentiation between epithelioid 
mesothelioma and lung adenocarcinoma. It has become the standard to 
use a panel of positive and negative immunohistochemical stains in the 
diagnosis of mesothelioma.  The Guidelines for Pathologic Diagnosis of 
Malignant Mesothelioma by International Mesothelioma Interest Group of 
2017 stated that there is variability between staining and laboratories and 
that there is no recommended panel of stains (Husain et al., 2018). Some 
of the stains used include the calretinin stain that is a calcium-binding 
protein that can be demonstrated in benign and malignant mesothelial 
cells. This stain is most commonly used to differentiate the epithelioid 
mesothelioma subtype, which would stain positive, from lung 
adenocarcinoma, which would stain negative (Chhieng et al., 2000). Other 
stains used in diagnosing mesothelioma include Cytokeratin 5 or 5/6, 
Wilms tumor-1 (WT1), Podoplanin (D2-40), Claudin 4, MOC31, 
carcinoembryonic antigen (CEA), thyroid transcription factor-1 (TTF-1), 
B72.3, BER-EP4 and BG8 (Husain et al., 2018).  
 
1.1.5.1.1 Mesothelioma subtypes  
 
There are three main histological types of mesothelioma namely 
epithelioid, sarcomatous and a mixed or biphasic type with both epithelioid 
and sarcomatous elements (Franklin et al., 2016). The World Health 
Organization (WHO) classification of tumours of the lung, pleura, thymus 
and heart (Travis et al., 2015) are used to classify mesotheliomas into 
their respective subtypes (Husain et al., 2018). Epithelioid subtypes are 
described to compose of polygonal, oval or cuboidal cells. The 
sarcomatous subtype is described to consist of spindle cells and the 
biphasic subtype can contain both epithelioid and sarcomatous areas 
within the same tumour (Husain et al., 2018).  
 
Patients diagnosed with the sarcomatous subtype, in particular, have a 
shorter median survival period of around 8 months, compared to 18 and 
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11 months for the epithelioid and the biphasic subtype, respectively (De 
Assis et al., 2014). It has been reported that patients with the epithelioid 
type respond better to treatment (Franklin et al., 2016). Studies have also 
reported (Bitchatchi et al., 2010; Thomas et al., 2015) an improved overall 
survival in younger patients diagnosed with mesothelioma. 
 
 
1.1.6 South African asbestos regulations 
 
In 2002, SA promulgated regulations to stipulate how to work safely with 
asbestos (Department of Labour, 2002). It was only in 2008 that South 
Africa prohibited the use, manufacturing, import and export of asbestos as 
well as asbestos-containing materials (Department of Environmental 
Affairs and Tourism, 2008). In so doing, South Africa joined 67 other 
countries that had banned asbestos (Kazan-Allen, 2019). 
 
 
1.1.7 Compensation systems 
 
Despite the banning of asbestos in South Africa in 2008 and the provision 
of regulations on how to work safely with asbestos, we continue to see 
cases of asbestos-related diseases, including mesothelioma (Murray et 
al., 2015; Phillips et al., 2016). The law makes provision for compensation 
of occupationally acquired asbestos-related diseases, including 
mesothelioma, under the Occupational Disease in Mines and Works Act, 
1973 (ODMWA) (Department of Health, 1973).  
 
The compensation system facilitates the submission of cardio-respiratory 
organs of deceased patients to the National Institute for Occupational 
Health (NIOH) for examination and diagnoses to assist with the 
compensation process. Pathological findings, which includes macroscopic 
and microscopic findings from the examination are stored in the Pathology 
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Automation Database (PATHAUT). The examinations are performed in 
accordance with a standard procedure. The lungs are cut in 1cm thick 
slices to examine macroscopically. Thereafter, a representative section of 
each of the zones of the lung is taken, together with sections of the main 
bronchus and lymph nodes, for microscopic examination. The sections 
undergo a fixation process and are embedded in wax. Sectioning is 
performed using microtomy and 4-micron thick sections are mounted on 
glass slides. Thereafter, routine stains are performed on these sections to 
determine fibrosis and detect ferruginous bodies. The pathologist will 
request immunohistochemistry to be performed on certain sections. 
Pleural malignant mesothelioma is diagnosed based on morphology and 
supported by immunohistochemical stains. The calretinin stain is most 
commonly used to differentiate the epithelioid mesothelioma subtype, 
which would stain positive, from lung adenocarcinoma, which would stain 
negative. This process was also described by Ndlovu and colleagues 
(Ndlovu et al.,2017). 
 
Part of the examination also includes determining the lung fibre burden of 
individuals with asbestos-related diseases. There are various methods to 
establish lung fibre burden such as light microscopy (LM), phase contrast 
microscopy (PCM), scanning electron microscopy (SEM) and transmission 
electron microscopy (TEM). Asbestos bodies are also seen during the lung 
fibre burden analysis. Asbestos bodies are formed when macrophages 
attempt to phagocytize amphibole asbestos fibres (Wenk, 1976). As a 
result, the asbestos fibres are coated with complexes of hemosiderin, 
ferritin and glycoproteins and bodies with a characteristic drumstick 
appearance are formed around the asbestos fibre (Wenk, 1976).  The 
methods used to analyse the lung fibre burden have advantages and 
disadvantages in detecting and analysing asbestos fibres as shown in 
Table1.2.
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Table 1.2: Advantages and disadvantages of methods used for detection and analysis of asbestos fibres in lung 
tissue (adapted from De Vuyst et al., 1998 & Roggli et al., 2010) 
 
Method  Advantages  Disadvantages 
Light microscopy Quick and easy 
Inexpensive 
Widely available 
Possible to detect low concentrations AB/ml or 3 AB/g 
Low resolution (only fibres thicker than 0,20 μm can be 
detected). Consequently, limited only to asbestos bodies and 
large fibres 
Does not enable identification of the fibre type 
Polarized light microscopy Quick and little preparation needed More operator skills required than for Light microscopy 
Interference microscopy Relatively inexpensive  
Fibre types can be identified 
Low resolution 
Some skill is required to identify different fibre types 
Phase contrast microscopy Relatively easy 
Inexpensive method 
Cannot distinguish between fibre types  
Resolution limit for fibres of 0,20 mm diameter 
Scanning electron microscopy 
 
More sensitive 
High resolution  
Identification of the fibre type and measurement of the fibre 
dimensions 
Allows for larger areas of tissue 
Time consuming 
Expensive 
Detection of concentrations below 5 fibres/ml or 5 000 
fibres/g is very time consuming 
Needs EDS to identify and distinguish the fibre types 
Transmission electron 
microscopy 
 
Most sensitive 
Identification of fibre type 
Fibres as thin as 0,01 μm can be detected 
Time consuming with more operator skills required than 
SEM. 
More expensive than SEM 
Not widely available 
Needs EDS or X-ray diffraction to identify and distinguish the 
fibre types 
  *AB – Asbestos bodies 
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At the NIOH, the lung fibre burden is determined by extracting the asbestos 
fibres from the lungs. The asbestos fibre types, fibre sizes and asbestos body 
concentration are determined by SEM together with Energy Dispersive 
Spectroscopy (EDS). This method is described in detail in Appendix A. The 
different types of asbestos display different EDS peaks upon analysis. When 
analysing asbestos bodies with EDS, peaks of the asbestos fibre with a much 
higher iron peak are displayed (Wenk, 1976). The findings on asbestos fibre 
type, fibre sizes and asbestos body concentrations are stored in the Electron 
Microscopy (EM) database. Figure 1.2 a) shows the characteristic asbestos 
body and Figure 1.2 b) displays asbestos fibres identified in lung tissue under 
SEM. 
 
 
 
 
Figure 1.2: Asbestos fibres and bodies identified in lung tissue under 
Scanning Electron Microscopy. a) Asbestos body with characterised 
drumstick appearance and b) Asbestos fibres. Photo courtesy of NIOH 
archives.  
 
 
Analysis of asbestos fibres retained in the lung can show the number of fibres, 
fibre types and fibre sizes that individuals have been exposed to (asbestos 
burden) (Phillips et al., 2012). Although chrysotile fibres are cleared from the 
lungs, amphiboles such as crocidolite appear to persist (Bernstein et al., 2015; 
a) Asbestos body with characterised drumstick appearance 
b) 
Asbestos 
fibres 
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Doll & Peto, 1985; Rees et al., 2001). The fibre burden of amphiboles reflects 
the cumulative number of fibres that individuals have been exposed to. The 
lungs can, therefore, be considered as a type of personal air sampler. 
 
Compensation for environmental asbestos-related diseases is a neglected 
issue (Ndlovu et al., 2013). Environmentally contracted asbestos-related 
diseases can only receive compensation through the ART/KRT if the criteria 
set out by the Trusts are met (Ndlovu et al., 2013).  
 
 
1.1.7.1 Asbestos Relief Trust and Kgalagadi Relief Trust 
 
The ART was formed in 2003, through a class action settlement against the 
Cape Public Limited Company (Plc) and the General Mining Corporation 
(Gencor) (teWater Naude, 2014a). This settlement made provision for 
claimants and environmental rehabilitation (teWater Naude, 2014a). The 
compensation that claimants receive is in addition to compensation received 
by mineworkers through the ODMWA (teWater Naude, 2014a). The KRT was 
formed in 2006, through a legal settlement against the Swiss Eternit Group. 
The Trust has enabled ex-miners of the Kuruman and Danielskuil Cape Blue 
Asbestos (KCBA and DCBA) mines to apply for compensation (teWater 
Naude, 2014b).  
 
The ART/KRT require environmental claimants with an asbestos-related 
disease to fulfil certain criteria to claim. In addition to having an asbestos-
related disease caused by environmental exposures, these criteria include 
having a domestic or neighbourhood exposure within 10km of an asbestos 
mine or mill. The claimants had to be exposed during the qualifying periods 
(1955 – 2002) and should have had no prior occupational exposure to 
asbestos (teWater Naude, 2014b). Outcomes of the compensation claims and 
where the exposure occurred are stored in the ART/KRT database. 
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The ART, from when it was established, was pro-active in their efforts. 
Trustees actively sought work records from founding companies, recognising 
claimants lack of resources and difficulty accessing these documentations 
needed for proof to claim (teWater Naude 2014b). The Trust also had 
enormous success in administering claims. In 2007, it was reported that 27% 
of claimants receive their awards within 6 months and 36% within 7 to 12 
months, 33% within 13 to 24 month and only 4% within more than 25 months. 
Given these successes, future Trusts may be able to learn from the ART/KRT 
model and develop a similar structure to ensure similar success. 
Compensation under the ODMW Act, on the other hand, has not had the 
same success. The compensation system does not serve its intended 
beneficiaries and calls for the fund to be managed more efficiently (Baker, 
1998; Ehrlich 2012a; Ehrlich 2012b; Maiphetlho & Ehrlich, 2010). 
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1.2 Literature Review 
 
1.2.1 Asbestos lung fibre burden  
 
Lung fibre burden analysis provides objective information about past 
exposures to asbestos (Kraynie et al., 2016). The presence of asbestos 
bodies is also indicative of the inhalation of asbestos fibres (Roggli et al., 
2010). In South Africa, there are a few studies that examined the asbestos 
lung fibre burden and typed the asbestos, using electron microscopy and 
EDS, in patients diagnosed with mesothelioma (Hiroshima et al., 1993; Nolan 
et al., 2006; Phillips and Murray 2010; Rees et al., 2001).  
 
Hiroshima and colleagues (1993) characterised asbestos fibres in 
mesothelioma tissues. The authors exposed baboons to the three types of 
asbestos and focused specifically on the translocation of fibres from the lung 
to other tissue (Hiroshima et al., 1993). Rees and colleagues (2001) studied 
asbestos lung fibre concentrations in chrysotile miners. The researchers found 
low fibre contents in the lungs of chrysotile mine workers and concluded that 
South African chrysotile is not heavily contaminated with tremolite.  
Nevertheless, contamination with the amphibole asbestos has been 
suggested to cause mesothelioma (Rees et al., 2001).  
 
The persistency of chrysotile in the lungs and the role it plays in causing 
mesothelioma, remain controversial. Research has shown that chrysotile 
fibres are cleared from the lungs by macrophages (Bernstein et al., 2015) 
however, they may still cause lung disease (Landrigan et al., 1999; Martinez-
Alier, 2001). 
 
Nolan and colleagues (2006) studied the lung content of forty-three 
mesothelioma cases from South Africa. The study characterised the asbestos 
fibres linked to mesothelioma. The study showed the major contribution of 
crocidolite and the smaller role of amosite and chrysotile in the etiology of 
mesothelioma cases (Nolan et al., 2006). Phillips and Murray 2010 described 
 
20  
  
a rare case of mesothelioma attributed to anthophyllite exposure, which was 
not commercially mined in South Africa.  
 
In other countries, there are studies on the analysis of asbestos lung fibre 
burden in mesothelioma cases. Gilham and colleagues (2016) found that due 
to the high consumption of amosite in Britain, amosite is a major contributor to 
mesothelioma incidences in the UK. Roggli and colleagues (2002) results 
illustrate mesothelioma in the USA are mostly attributable to the commercial 
amphiboles, amosite and crocidolite. In Australia, mesothelioma cases are 
due to crocidolite exposure from the Wittenoom area, the site of a crocidolite 
mine (de Klerk et al., 1996). Berman and Crump (2008) performed a meta-
analysis and concluded that amphiboles were more potent in causing 
mesothelioma than chrysotile, but still rejected the hypothesis that pure 
chrysotile cannot cause mesothelioma.   
 
 
1.2.2 Mesotheliomagenic potential 
 
Research has indicated that certain types of asbestos fibres are more likely to 
cause mesothelioma than others (Rees et al., 1999; Nolan et al., 2006; White 
et al., 2008). Crocidolite is more likely to cause mesothelioma than amosite 
and chrysotile, and the mesotheliomagenic potential fibre gradient for South 
Africa has been proposed as crocidolite>amosite>chrysotile (Rees et al., 
1999) and supported by other studies (Nolan et al., 2006; Murray & Nelson, 
2008; White et al., 2008). 
 
 
1.2.3 Length of fibres and pathogenicity  
 
There is controversy regarding the fibre length and the role it plays in potential 
pathogenicity of asbestos-related diseases (Roggli 2015; Phillips et al., 2016; 
Eligman & Tran, 2016). Several in vitro, animal and epidemiological studies 
have been conducted to determine which fibre sizes are more pathogenic 
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(Tilkes & Beck 1980; Stanton et al., 1981; Davis & Jones 1988; Suzuki et al., 
2005; Berman & Crump 2008). Although the pathogenic role of asbestos fibres 
longer than 5 µm is well-established, Authors have expressed their concern 
not to disregard short fibres in the pathogenicity of asbestos-related diseases 
(Dodson et al., 2003; Lemen et al., 2006; Suzuki et al., 2005). These and 
other studies suggested not to disregard short fibres until further research is 
done to fully understand the role of fibre length in the pathogenicity of 
asbestos-related diseases (Phillips et al., 2016; Barlow, Grespin & Best 2017; 
Boulanger et al., 2014).   
 
 
1.2.4 Association between mesothelioma subtype and asbestos 
 
There are very few publications on the relationship between exposure 
characteristics, such as asbestos fibre type, and mesothelioma subtypes 
(Franklin et al., 2016). A study by Klebe and colleagues (2010) reported that 
patients with the sarcomatous subtype had significantly more amosite fibres in 
their lungs. However, neither the exposure information was provided, nor the 
number of amosite fibres within the lungs. Furthermore, Haber & Haber (2011) 
concluded that there was no association between exposure frequency or 
intensity and histological subtype. The researchers, however, did not report on 
fibre types. A more recent study in Australia found no significant relationship 
between exposure characteristics and histological subtypes of mesothelioma 
(Franklin et al., 2016). The analyses were only performed on the proportion of 
the study population that was from Wittenoom, the site of a crocidolite mine in 
Australia, where crocidolite exposure dominated as evident in their results 
showing that 98.3% of lung tissue samples from mesothelioma patients 
contained crocidolite.  
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1.3 Problem statement 
 
Evidence has shown that exposure to asbestos is the major cause of 
mesothelioma. However, exposure to various types and burden of asbestos 
fibres may lead to varying clinical manifestation and prognosis of 
mesothelioma (Brcic & Kern 2020). Furthermore, the modality of treatment, 
prognosis and survival from mesothelioma is partly related to the histological 
types. Although asbestos is the leading cause of all mesothelioma types, 
however, it is not clear if exposure to a particular type of asbestos fibres can 
be linked with a specific histological type of mesothelioma. 
 
Given South Africa’s unique asbestos mining history, three types of asbestos 
can be studied. This enables us to study any relationships between asbestos 
lung fibre burden and the development of the mesothelioma subtypes. 
 
There are no South African studies determining the relationship between 
asbestos exposure characteristics and the development of the three main 
histological subtypes of mesothelioma. Understanding these relationships may 
provide insight into how mesothelioma subtypes develop and assist with future 
treatment strategies. 
 
1.4 Aim 
 
The aim of this study was to describe data collected on individuals diagnosed 
with mesothelioma at the NIOH. The associations between the asbestos type, 
fibre size and burden and mesothelioma subtype were also analysed. 
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1.5 Objectives 
 
1. To describe and compare the environmental and occupational cases of 
mesothelioma in terms of demographic characteristics and ART/KRT 
compensation outcomes. 
2. To describe the asbestos fibre burden in terms of the number, type and size of 
the asbestos fibres, as well as the number of asbestos bodies.  
3. To describe the association between the histological morphology of 
mesothelioma and the type, size and number of asbestos fibres. 
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CHAPTER TWO – METHODS 
 
This chapter describes the research design and the process used to collect, 
analyse and interpret data. Secondary data on mesothelioma cases were 
extracted from three different databases namely PATHAUT, ART/KRT and the 
Electron Microscopy (EM) database of the NIOH.  
 
 
2.1 Study Design 
 
This study was a retrospective cross-sectional secondary analysis of three 
administrative databases. These databases contained information on 
individuals with mesothelioma diagnosed at autopsy at the NIOH for the 11-
year period from 2006 – 2016. The period was chosen as both autopsy data 
and data for fibre analysis were available for this time. 
 
 
2.2 Methodology 
 
2.2.1 Study population  
 
This study comprised all deceased miners, ex-miners and ART/KRT claimants 
histologically diagnosed with mesothelioma at autopsy, whose data had been 
captured on the PATHAUT database for the period Jan 2006 – Dec 2016 (11 
years).  
 
 
2.2.2 Data collection  
 
All data were extracted electronically. Data of individuals pathologically 
diagnosed with mesothelioma were extracted from the PATHAUT database. 
This data included demographics such as age, sex, employment histories and 
detailed pathology findings of the respiratory organs examined. Records 
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retrieved from the ART/KRT database was linked against the records 
extracted from the PATHAUT database to obtain additional information 
regarding the ART/KRT compensation outcomes. The key variable or unique 
identifier for the data linkage was the patient’s South African Identification 
Number. 
 
Data concerning the asbestos lung fibre burden, asbestos fibre counts, 
asbestos types and fibre sizes and concentrations were obtained from the EM 
Unit database within the NIOH Pathology Department.  
 
PATHAUT was the main source of data and the ART/KRT and EM records 
were linked to the main source to obtain additional information on 
compensation outcomes and asbestos lung fibre burden. The variables used 
in each data set are shown in Appendix B. 
 
 
2.2.3 Data management 
 
The deceased individuals’ information from the PATHAUT database were 
linked to records from the ART/KRT database. The records were linked by 
using the South African identification number. Only those records that linked to 
records from the PATHAUT database were used. Records that did not have a 
South African ID could not be linked and were therefore excluded from the 
ART/KRT compensation outcome analysis.  Records from the EM database 
were also linked to records from the PATHAUT database. These records were 
linked using the laboratory number assigned to each autopsy case. After 
linking the data frothed three databases and completing data validations, a 
unique code was created for each case. 
 
The variable name milemeso in the PATHAUT database was utilised to 
identify the 270 cases of mesothelioma that were recorded in the study period 
(2006 -2016). 
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The variable name milmesar in the PATHAUT database represented all the 
mesothelioma cases with sarcomatous histological type. The variable 
milmesep represented all epithelioid histology subtype. The third histology 
subtype is Biphasic (both types). A new variable containing the three 
categories of the histology subtype was generated from “milmesep” and 
“milmesar” and utilized for further analysis. 
 
 
2.2.3.1 Variables descriptions  
 
For objective one, the demographic characteristics such as age, sex, region, 
employment history and commodity exposure were described. The 
compensation outcomes, (whether the family received compensation or not for 
the ART/KRT cases) was also described. For objective two, the asbestos lung 
fibre burden was described in terms of the asbestos types and fibres per gram 
of dry weight of lung tissue. The asbestos fibre sizes were described in the 
ranges of 1-5 µm, ≥5-10 µm and >10 µm. Asbestos burden or concentration of 
fibres per gram of dry weight of lung tissue was described in ranges (1 – 999 
999, 1 000 000 – 2 999 999, ≥3 000 000). For objective three, the histological 
morphology of mesothelioma was described for the subtypes epithelioid, 
sarcomatous or biphasic (mixed). The histological subtype was the dependent 
variable and the explanatory variables were the asbestos types, fibre size and 
the asbestos fibre burden. The missing values in the datasets were coded as 
“unknown”. 
 
 
2.2.3.2 Data validation 
 
Validation was performed on the data. The SA ID number was only used to 
check for consistencies in sex as well as age. Where discrepancies were 
found, sex and/or age was changed as indicated by the SA identification 
number. Data were also checked for duplications and any missing values. 
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2.2.4 Data analysis  
 
The merged data in Excel was imported into Stata version 16 (StataCorp, 
USA) statistical software for further analysis. For objective one, descriptive 
statistics and tabulation were conducted for categorical and continuous 
variables. Bivariate analysis was conducted to determine the relationship 
between demographic and regional variables and the asbestos exposure 
types (occupational or environmental). Analysis involving categorical variables 
such as sex, region and exposure types was conducted using the Pearson’s 
Chi-square (Fischer’s exact test was utilised when the expected frequency 
was less than 5 in more than 25% of the cells). The mean difference of 
continuous variables (such as age) across exposure types (occupational or 
environmental) was assessed using the Student’s independent t-test. 
Similarly, Chi-square and Student’s t-test was utilised to respectively assess 
the relationship between categorical and continuous variables and the 
compensation outcome.  
 
For objective two, mean and standard deviation, range, frequency and 
percentages were utilised to describe the type, fibre size and burden of 
asbestos in the lungs. The relationship between the aforementioned 
explanatory variables and asbestos exposure (occupational and 
environmental) was respectively conducted using the Student’s t-test and Chi-
Square (or Fischer’s exact in appropriate condition) for the continuous and 
categorical variable. Equality of variance was also assessed before 
conducting either student’s t-test for equal or unequal student’s t-test as 
appropriate.  
 
For objective three, the relationship between mesothelioma subtypes 
(categorical) and asbestos types (categorical), fibre sizes (categorical) and 
asbestos burden ranges (categorical) was assessed using the Pearson’s Chi-
square tests. Furthermore, one-way analysis of variance (ANOVA) was 
conducted to assess the differences in the mean levels of continuous 
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variables such as asbestos fibres across the three categories of histological 
types of mesothelioma. A post hoc Bonferroni test was conducted when the p-
value of ANOVA was statistically significant to determine where the pairwise 
difference(s) lie. A two-tailed test of the hypothesis was assumed and a P-
value < 0.05 was assumed to be statistically significant. 
 
 
2.3 Ethical Considerations 
 
The Occupational Disease in Mines and Works Act No. 78 of 1973 makes 
provision for the cardio-respiratory organ to be sent to the NIOH only if the 
relatives of deceased individuals give consent (Appendix C). The Human 
Tissue Act of 1983 and the National Health Act of 2003 together with the 
consent, make provision for the tissue to be kept for diagnostics, medical 
education, research and scientific purposes. Ethical approval was obtained 
from the University of Johannesburg prior to the commencement of the study. 
The certificate, with the NHREC registration number 241112-035 is included 
as Appendix D.  
 
In addition, ethical clearance from the Human Research Ethics Committee 
(Medical) at the University of the Witwatersrand to study the demographic, 
exposure and pathological data collected on deceased miners and ex-miners 
in the PATHAUT database was obtained and renewed every five years. The 
clearance certificate number is M170879 (Appendix E).  
 
Written permission was obtained from the data keeper of the ART/KRT before 
the retrieval of data from the ART/KRT database. A unique study code was 
created to represent the identification of the deceased. Access to the datasets 
was password protected to prevent any other person from accessing it. Only 
the main investigator had access to the data.  
 
29  
  
 
CHAPTER THREE – RESULTS  
 
This chapter describes the study population demographics and other statistical 
results obtained after analysing the data from the PATHAUT, ART/KRT and 
the EM databases. For the study period Jan 2006 – Dec 2016 (11 years), 270 
cases of mesothelioma were identified in the PATHAUT database.  
 
3.1 Demographic Data 
 
Of the 270 mesothelioma cases identified in the PATHAUT database, 89.3% 
(95% CI: 84.9% - 92.4%, n=241) were occupationally exposed to asbestos 
and 10.7% (95% CI: 7.6% - 15.1%, n=29) were environmentally exposed as 
presented in Figure 3.1. 
 
 
 
Figure 3.1. Pie chart showing the pattern of Asbestos exposure of the 
mesothelioma cases. 
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The mean age of all the individual mesothelioma cases was 64.0± 10.8years. 
Furthermore, the mean age of the occupationally exposed cases was similar 
to the mean age of the environmentally exposed cases (occupation vs 
environment: 64.09 ± 10.8) years vs 64.3 ± 10.8 years, P-value = 0.8787). 
Nearly four-fifths of the mesothelioma cases were males (n= 214, 79.3%). The 
majority of the occupationally exposed cases where male patients (86.3%, 
n=208), while the majority of the environmentally exposed cases were female 
(65.5%, n=19) Table 3.1.1. There was no statistically significant difference 
between the mean age among male and female mesothelioma patients (Male 
vs Female: 63.8 ± 10.9 years vs 64.9 ± 10.3 years, P-value = 0.516).  
More than half of the occupational (62.2%,n=150) and environmental (58.6% 
,n=17) cases came from the Northern Cape Province and the highest 
proportion of the deceased patients (29.9%, n=72) last worked for GEFCO 
followed by Impala Platinum (6.2%, n=15) and  Iscor 4.6% (n=11). There was 
an increase in autopsies for miners who were employed between the years 
1970 to 1979. The increase went from 15.6% in the 1960s to 35.6% in the 
1970s. The mean years of exposure were 13.5 ± 11.3 years. The mean years 
of exposure among the environmentally exposed cases (23.5 ± 2.1 years) was 
higher than the mean years of exposure among the occupationally exposed 
cases (13.4 ± 11.3 years) as shown in Table 3.1.1. 
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Table 3.1.1 Demographic characteristics, region and annual 
mesothelioma diagnosis stratified by asbestos exposure. 
 
Characteristics 
                  Asbestos exposure Total 
N= 270, (%) 
P-value Environmental,  
N= 29, (%) 
Occupational,  
N = 241 (%) 
Age (mean ±SD) years 64.3 ± 10.8 
64.0 (± 10.8) 64.0 ± 10.8 0.8787$ 
40-49 2 (8.3) 15 (6.3) 17 (6.5) 0.749 Ω 
50-59 5 (20.8) 81 (34.2) 86 (33.0)  
60-69 8 (33.36) 66 (27.9) 74 (28.4)  
70-79 7 (29.2) 54 (22.8) 61 (23.4)  
80 and above 2 (8.3) 21 (8.9) 23 (8.8)  
Sex 
Female 19 (65.5) 30 (12.5) 49 (18.2) < 0.001^* 
Male 6 (20.7) 208 (86.3) 214 (79.3)  
Unknown 4 (13.8) 3 (1.2) 7 (2.6)  
Province  
Northern Cape 17 (58.) 150 (626.2) 167 (61.9) 0.279^ 
Gauteng 5 (17.2) 30 (12.5) 35 (13.0)  
North West 0 (0.0) 25 (10.4) 25 (9.3)  
Eastern Cape 0 (0.0) 1 (0.4) 1 (0.4)  
Free State 0 (0.0) 6 (2.5) 6 (2.22)  
Limpopo 0 (0.0) 1 (0.4) 1 (0.4)  
Mpumalanga 1 (3.5) 4 (1.7)   5 (1.9)  
Western Cape 0 (0.0) 2 (0.8) 2 (0.7)  
Foreign 0 (0.0) 1 (0.4) 1 (0.4)  
Unknown 6 (20.7) 21 (8.7) 27 (10.0)  
Miners Job Commencement date  
1940-1949 0 (0.0) 5 (2.1) 5 (1.9) < 0.001^* 
1950-1959 0 (0.0) 27 (11.2) 27 (10.0)  
1960-1969 1 (3.4)  41 (17.0) 42 (15.6)  
1970-1979 1 (3.4) 95 (39.4) 96 (35.6)  
1980-1989 0 (0.0) 45 (18.7) 45 (16.7)  
1990-1999 0 (0.0) 2 (0.8) 2 (0.7)  
≥2000 0 (0.0) 3 (1.2) 3 (1.1)  
Unknown 27 (93.1) 23 (9.5) 50 (18.5)  
Year of diagnosis 
2006 0 (0.0) 2 (0.8) 2 (0.7) 0.386^ 
2007 1 (3.5) 3 (1.2) 4 (1.5)  
2008 7(24.1) 30 (12.5) 37(13.7)  
2009 0 (0.0) 9 (3.7) 9 (3.33)  
2010 4 (13.8) 24 (10.0) 28 (10.4)   
2011 2 (6.9) 32 (13.3) 34 (12.6)   
2012 6 (20.7) 36 (14.9) 42 (15.6)  
2013 2 (6.9) 30 (12.5) 32 (11.9)   
2014 5 (17.2) 30 (12.5) 35 (13.0)  
2015 2 (6.9) 25 (10.4) 27 (10.0)  
2016 0 (0.0) 20 (8.3) 20 (7.4)  
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Last mining site 
GEFCO - 72 (29.9)   
Impala Platinum - 15 (6.2)   
Iscor - 11 (4.6)   
Cape Blue - 10 (4.1)   
Industry - 10 (4.1)   
Pomfret Asbestos Mine - 9 (3.7)   
Hotazel Manganese 
Mine 
- 8 (3.3)   
Gencor - 7 (2.9)   
Associated Manganese - 6 (2.5)   
Asbestos Mine - 5 (2.1)   
ESKOM - 5 (2.1)   
¥Others - 69 (28.6)   
Unknown - 14 (5.8)   
Length of exposure 
(Mean ± SD) years 
23.5 ± 2.1 13.4±11.3 13.5 ± 11.3 < 0.0001$ 
 
¥Others are companies with less than 5 cases. *Statistically significant at P-value < 0.05.  SD: Standard 
deviation. $Student’s t-test, ^Fischer’s exact test, ΩPearson’s Chi-square 
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3.2 Exposure Data  
 Of the 270 mesothelioma cases, 10.7% (n=29) were environmentally 
exposed. The remaining 89.3% (n=241) occupational cases mostly worked in 
different mineral mines which resulted in mixed exposures. The exposure data 
is, however, based on the longest service history. Nearly half of the 
occupational cases, (46.5%, n=112) had their longest service in the asbestos 
mining industry with a mean length of service of 5.8 ± 6.5 years as presented 
in Table 3.2.1.   
  
Table 3.2.1 Number of occupational cases by commodity most exposed 
to and mean exposure years. 
  
Commodity most exposed to  Total number of cases (%) 
Length of exposure  
(Mean ± SD), years  
Asbestos  112 (46.5)  5.8 ± 6.5   
Gold  25 (10.4)  20.6 ± 11.5   
Platinum  25 (10.4)  17.9 ± 9.9   
Manganese  21 (8.7)  17.9 ± 10.7   
Industry  10 (4.1)  20.6 ± 14.1   
Iscor  8 (3.3) 17.4 ± 8.8   
Coal  7 (2.9) 18.9 ± 13.0   
Diamond  7 (2.9)  14.2 ± 15.9   
Eskom  5 (2.1)  31.6 ±  6.5 
Iron  3 (1.2)  16.7 ± 11.0   
SA Railways  3 (1.2)  22.0 ± 12.5   
Unknown  7 (2.9)  0.0   
*Other  8 (3.3)  12.9 ± 12.3   
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3.3 Compensation Outcomes  
Of the 270 mesothelioma cases identified in the PATHAUT database, 54.4% 
(n=147) were referred by the ART/KRT to the NIOH. Of the referred cases, 
87.8% (n=129) qualified to claim compensation, while 12.2% (n=18) did not 
meet the compensation criteria.  Furthermore, Table 3.3.1 showed that a 
higher percentage of patients who had occupational asbestos exposure were 
paid as compared to the percentage of environmentally exposed patients that 
were paid (51.5% vs 17.2%; P-value = 0.001). 
 
Table 3.3.1 Compensation outcome by type of asbestos exposure. 
ART/KRT 
compensation 
outcomes 
                  Asbestos exposure Total 
N= 270, (%) 
P-value 
Environmental 
N= 29, (%) 
Occupational,  
N = 241 (%) 
  
Paid 5 (17.2) 124 (51.5) 129 (47.8) 0.001* 
Not paid 5 (17.2) 13 (5.4) 18 (6.7)  
Unknown  19 (65.5) 104 (43.2) 123 (45.6)  
 
From Table 3.3.2 below, there was no statistically significant difference in the 
pattern of payment of compensation according to age (P-value = 0.2132), sex 
(P-value = 0.237) and year period of diagnosis (P-value = 0.119). However, 
there was a statistically significant relationship between the province of 
diagnosis and compensation outcome (P-value = 0.004). Northern Cape 
province had the highest mesothelioma cases with a higher percentage of 
patients that received compensation as compared to patients who were not 
compensated in the Province (89.2% vs 77.8, P-value = 0.004). 
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Table 3.3.2 ART/KRT compensation outcomes by demographic and 
provincial characteristics.   
Characteristics 
Compensation outcome 
Total P-value Not Paid 
N, (%) 
Paid 
N, (%) 
Age (mean ± SD) years 64.7± 8.9 61.6 ± 9.8 62.0 ± 9.7 0.2132£ 
Sex     
Female 6 (33.3) 27 (20.9) 33 (22.5) 0.237$ 
Male 12 (66.7) 102 (79.1) 114 (77.6)  
Province 
Northern Cape 14 (77.8) 115 (89.2) 129 (87.8) 0.004*^ 
North West 0 (0.0) 10 (7.8) 10 (6.8)  
Gauteng 2 (11.1) 1 (0.8) 3 (2.0)  
Free State 0 (0.0) 3 (2.3) 3 (2.0)  
Eastern Cape 1 (5.6) 0 (0.0) 1 (0.7)  
Mpumalanga 1 (5.6) 0 (0.0) 1 (0.7)  
Year period of diagnosis 
2006 – 2009 1 (5.6) 24 (18.6) 25 (17.0) 0.381$ 
2010 – 2013 11 (61.1) 66 (51.2) 77 (52.4)  
2014 – 2016 6 (33.3) 39 (30.2) 45 (30.6)  
£: Student’s t-test; $ Pearson’s Chi-square. ^ Fischer’s exact test.  
*Statistically significant at P-value< 0.05 
   
 
 
3.4 Asbestos Fibre Burden 
 
Of the 270 mesothelioma cases identified, 97.0% (n=262) were sent for 
asbestos fibre analyses. Of these, 90.8% (n=238) were occupational cases 
and 9.2% (n=24) were environmental cases. Only Crocidolite was found in the 
lungs of about half (n= 140, 53.4%) of the mesothelioma cases and no 
asbestos fibre was identified in about one-third of cases (n= 98, 37.4%). There 
was no statistically significant difference in the pattern of asbestos fibres that 
were found among the environmentally and occupationally exposed cases (P-
value = 0.507) Table 3.4.1. Of the cases that contained only crocidolite fibres, 
92.1% (n=129/140) were occupational and 7.9% (n=11) were environmental 
cases. 
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Table 3.4.1. Type of asbestos fibre among mesothelioma cases based on 
the pattern of exposure. 
 
 Asbestos type 
                  Asbestos exposure 
Total 
N= 262, (%) 
P-value Environmental 
N= 24, (%) 
Occupational 
N = 238 (%) 
Crocidolite 11 (45.8) 129 (54.2) 140 (53.4) 0.419^ 
Amosite and 
Crocidolite 
0 (0.0) 15 (6.3) 15 (5.7)  
Amosite 1 (4.2) 7 (2.9) 8 (3.1)  
Amosite and 
Chrysotile 
0 (0.0) 1 (0.4) 1 (0.4)  
No Asbestos 
fibres identified 
12 (50.1) 86 (36.1) 98 (37.4)  
^ Fischer’s exact 
 
 
3.5 Histological Features of Mesothelioma  
The histological features of the mesothelioma cases are presented in Table 
3.5.1.  Nearly two-thirds (n=64.4%, n=174/270) of the Mesothelioma cases 
were of the Epithelioid histological type. The next common histological type 
was the Biphasic type (23.3%, n=63/270) (Table 3.5.1) Furthermore, the 
predominant histological type among the environmentally exposed (69.0%) 
and occupationally (63.9%) exposed patients was the epithelioid subtype. 
There was no statistically significant difference in the histological pattern 
among the environmentally exposed cases as compared to the occupationally 
exposed cases. (P-value = 0.649) as presented in Table 3.5.1 
Table 3.5.1 Histological features of mesothelioma cases by exposure 
type. 
Histological type                      Exposure type Total 
N=270, (%) 
P-value 
Environmental Occupational 
Epithelioid 20 (69.0) 154 (63.9) 174 (64.4) 0.649$ 
Biphasic  7 (24.1) 56 (23.2) 63 (23.3)  
Sarcomatous  2 (6.9) 31 (12.9) 33 (12.2)  
$ Pearson’s Chi-square test 
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Table 3.5.2 Pattern of age and sex across the histological types of 
mesothelioma. 
Characteristics  
                    Histological types 
P-value 
Epithelioid Biphasic Sarcomatous 
Age (mean ± SD) Years 63.6 ± 11.2 62.8 ± 9.9 68.8 ± 9.4 0.0237¥ 
Sex     
Female 33 (19.0) 13 (20.6) 3 (9.1) 0.654^ 
Male 136 (78.2) 49 (77.8) 29 (87.9)  
Unknown 5 (2.9) 1 (1.6) 1 (3.0)  
¥One-way Analysis of variance test; ^Fischer’s exact test 
 
The mean age of individuals with different histological types of mesothelioma 
is displayed in Table 3.5.2. Individuals with the sarcomatous subtype had the 
highest mean age of 68.8 ± 9.4 years while individuals with the Biphasic type 
had the lowest mean age of 62.8 ± 9.9 years. The one-way analysis of 
variance showed that there was a statistically significant difference in mean 
age across the histological subtypes, P-value = 0.0237. The post-hoc 
Bonferroni test showed that the difference was between the mean age of 
individuals who had Sarcomatous and Biphasic (68.8 ±  9.4 vs 62.8 ± 9.9, P-
value = 0.030); and between individuals with Sarcomatous and Epithelioid 
histological subtype (68.8 ±  9.4 vs 63.6 ± 11.2, P-value = 0.034). There was 
no statistically significant difference in the mean age of individuals who had 
Biphasic and Epithelioid histological types (62.8 ± 9.9 vs 63.6 ± 11.2, P-value 
= 1.00).  Furthermore, there was no statistically significant difference in the 
pattern of histological subtypes of mesothelioma among females as compared 
to males (P-value = 0.654) as shown in Table 3.5.2  
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3.6 Fibre Burden per Mesothelioma Subtype  
   
The mean concentration and range of fibres by exposure type is presented in 
Table 3.6.1. The mean concentration of asbestos fibres in the lungs of 
mesothelioma patients was 2939321 ± 9964.4 million per gram of dried lungs 
and was the highest concentration of asbestos fibres in the lungs. Generally, 
the mean concentration of the various types of asbestos bodies and fibers 
was higher among the lungs of mesothelioma patients that were designated 
as occupationally exposed as compared to the lungs of patients with 
environmental exposure (Table 3.6.1).  
 
Table 3.6.1 Asbestos bodies and fibre counts by exposure type (millions 
per gm of dried lung)    
Asbestos 
characteristics 
Occupational 
Mean ± SD, 
(Range) 
Environmental 
(Mean ± SD), 
(Range) 
Total 
(Mean ± SD), 
(Range) 
£P-value 
Asbestos 
bodies 
 
339730.9 ± 11664.5 
 
(0 - 12600000) 
 
45388.92 ± 94847.7 
 
(0   -   386645) 
312768.3   ± 1115.1 
 
(0 - 12600000) 
0.0002 
Asbestos 
fibres 
 
3180292 ±10400000 
 
(0 - 92100000) 
 
549698 ± 1824964 
 
(0 - 8791489) 
2939321 ± 9964.4 
 
(0 - 92100000) 
0.0008 
Crocidolite 1122159 ± 4086234 
(0 -   47000000) 
268395.7± 942343.2 
(0 – 4576008) 
1043952 ± 3911657 
(0 -   47000000) 
0.0101 
Amosite 
60502.2 ± 488711.2 
 
(0 -   6442069) 
 
423.7 ± 2075.7 
 
(0 - 10169) 
 
54998.83 ± 466024 
 
(0 -   6442069) 
0.0591 
Chrysotile 
2.6 ± 40.2 
(0 -    620) 
0.0 
2.6 ± 40.2 
- 
- 
£Student’s t-test 
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Table 3.6.2 shows the pattern of asbestos bodies and fibre counts by histological type among the environmentally - and 
occupationally exposed patients. Of the occupational cases, the epithelioid subtype had the highest mean number of 
asbestos fibres, asbestos bodies and crocidolite fibres. The highest mean number of amosite fibres occurred among the 
biphasic subtype. However, the one-way analysis of variance showed that the mean concentration of the various asbestos 
fibres was not statistically different across the histological types. Of the environmental cases, the epithelioid subtype had the 
highest average number of asbestos fibres and the highest average number of crocidolite fibres. Asbestos bodies were only 
identified in the epithelioid subtype.   
Table 3.6.2 Asbestos bodies and fibres counts per mesothelioma subtype (millions per gm of dried lung). 
Asbestos 
fibres 
Occupational P-value Environmental ¥P-value 
Epithelioid 
(Mean ± SD) 
Biphasic 
(Mean ± SD) 
Sarcomatous 
(Mean ± SD) 
 Epithelioid 
(Mean ± SD) 
Biphasic 
(Mean ± SD) 
Sarcomatous 
(Mean ± SD) 
 
Asbestos 
bodies 
418617.3 ± 
1369760.7 
(0 - 12 604 909.0) 
277 991.2 ± 
804634.86 
 
(0 - 4 288 916.0) 
62 471.1 ± 
147019.4 
 
(0 - 584 099.0) 
0.2735 64 078.5 ± 
107978.81 
 
(0 - 386 645.0) 
0(0-0) 0(0-0) - 
Asbestos 
fibres 
4 305 486.7 ± 
12732351 
 
(0 - 92 100 633.0) 
1 248 759.7 ± 
3234998.9 
 
0 - 16833 994.0 
1 090 117.3 ± 
1911436.7 
 
(0 - 6 124 898.0) 
0.0851 728 206.4 ± 
2158220.1 
 
(0 - 8 791 489.0) 
92 718.3 ± 
197146.3 
 
(0 - 491 665.0) 
256 936.0 ± 0.0 
 
(0 - 256 936.0) 
0.7703 
Crocidolite 1542616.1   
5029988.6 
 
0 - 46 955 632.0 
395855.2 ± 
937251.32 
 
(0 - 5523 175.0) 
349166.4 ±   
707094.82 
 
(0 - 2 372 658.0) 
0.1075 359574.2± 
1115324 
 
0 - 4 576 008.0 
40033.0 ± 
83075.646 
 
0 - 207 495.0 
88 536.0 ± 0 
 
0 - 88 536.0 
0.7763 
Amosite 44927.0 ± 
318188.2 
 
(0 - 3 226 637.0) 
124272.0 ± 
868509.6 
 
(0 - 6442 069.0) 
23731.0 ± 
96924.8 
 
(0 - 508 216.0) 
0.5329 598.2 ± 2466.3 
 
(0 - 10169.0) 
0.0 0.0 - 
Chrysotile 4.1 ± 50.3 
 
(0 - 620.0) 
0.0 0.0 - 0.0 0.0 0.0 - 
¥ ANOVA test 
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Table 3.6.3 Mean concentration of fibres sizes per mesothelioma subtype (millions per gm of dried lung µg).  
   
Occupational cases  
        
Asbestos type   Crocidolite*   Amosite*   Chrysotile*  
Fibre size (µm)  1-5 
Mean ± SD 
>5 - 10 
Mean ± SD 
 >10 
Mean ± SD 
1-5 
Mean ± SD 
>5 - 10 
Mean ± SD 
>10 
Mean ± SD 
1-5 
Mean ± SD 
>5 - 10 
Mean ± SD 
>10 
Mean ± SD 
Epithelioid  
443972.0 ± 
1578011.3 
644023.1± 
2236788.7 
 454606.1± 
1493316 
20485.3± 
161395.2 
16383.6± 
126438.8 
8058.0± 
49272.1 
0.0 0.0 4.1 
Biphasic  101575.8± 
359481.4 
142661.3± 
335642.6 
 151607.7± 
342878.6 
41450.0± 
302087 
32538.7± 
226611.1 
50283.3± 
340045.6 
0.0 0.0 0.0 
Sarcomatous  52238.1 ± 
127165.2 
139176.0± 
299715.2 
 157740.4± 
327522.5 
0.0 3050.8± 
14619.5 
20679.3± 
93056.8 
0.0 0.0 0.0 
¥P-value 0.1133 0.1207  0.1874 0.6206 0.6523 0.2935 - - - 
Environmental cases  
        
   Crocidolite*   Amosite*     
  
  
Fibre size (µm)  1-5 
Mean ± SD 
>5 - 10 
Mean ± SD 
 >10 
Mean ± SD 
1-5 
Mean ± SD 
>5 - 10 
Mean ± SD 
>10 
Mean ± SD 
Epithelioid  27415.7 ± 
90113.0 
109149.6± 
306629.9 
 223005.9± 
806913 
0.0 598.1 0.0 
Biphasic  3555.7 ± 
8709.6 
20963.0± 
37671.9 
 15512.7 ± 
37998.1 
0.0 0.0 0.0 
Sarcomatous  0.0 59024.0 ± 0  29512.0 ± 0 0.0 0.0 0.0 
¥P-value 0.7902 0.7853  0.8114 - - -    
  * Fibres per µg dry weight;  ¥P-value of ANOVA    
 
The mean concentrations of fibres categorised in sizes are displayed in Table 3.6.3. The analysis of variance showed that 
there were no statistically significant differences in the sizes of the asbestos fibres across histological types.  
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3.7 Relationship Between Asbestos Type, Fibre Sizes, Burden and 
Mesothelioma Subtypes  
  
Of the 270 mesothelioma cases in this study, 164 cases were used to 
establish the relationship between mesothelioma subtype and asbestos type. 
These cases had both mesothelioma subtype and asbestos type identified. 
The relationship between asbestos fibres and the histological type of 
mesothelioma is displayed in Table 3.7.1. There was no statistically significant 
relationship between the asbestos fibres and the histological types (P-value = 
0.508).  The majority of the lungs of the mesothelioma cases had similarly 
high proportions of crocidolite across the histological subtypes (epithelioid vs 
biphasic vs sarcomatous: 85.3% vs 88.9% vs 78.9%, P-value = 0.508). 
 
Table 3.7.1 Relationship between histological mesothelioma cases by 
asbestos fibre type and mesothelioma subtype.  
  
 Asbestos fibres 
Epithelioid 
n, % 
Biphasic 
n, % 
Sarcomatous 
n, % 
Total 
n, % 
P-value 
Crocidolite  93 (85.3) 32 (88.9) 15 (78.9) 140 (85.4) 0.508^ 
Amosite and Crocidolite  8 (7.3) 4 (11.1) 3 (15.8) 15 (9.2)  
Amosite  7 (6.4) 0 (0.0) 1 (5.3) 8 (4.9)  
Amosite and Chrysotile  1 (0.9) 0 (0.0) 0 (0.0) 1 (0.6)  
Total  109 36 19 164  
^ Fischer’s exact test 
 
 
The relationship between asbestos fibre sizes, the number of fibres and 
mesothelioma subtype are presented in Table 3.7.2. For crocidolite fibre size 
1-5 µm and asbestos fibre amounts: 0, 1 – 999 999, 1 000 000 – 2 999 999, 
≥3 000 000, there was no statistically significant association across the 
histological subtypes (P-value =0.642). The same was observed for crocidolite 
>5-10 µm (P-value =0.458), crocidolite >10 µm (P-value = 0.836).   
For amosite 1-5 µm and asbestos fibre amount: 0, 1 – 999 999, 1 000 000 – 2 
999 999, ≥3 000 000, no significant association was found between the 
histological subtypes (P-value =0.675). Similarly, there was no statistically 
significant relationship for amosite >5-10 µm (P-value =0.749) and amosite 
>10 µm (P-value =0.343) and the histological types.  
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 Table 3.7.2. Relationship between asbestos fibre sizes ranges and mesothelioma subtypes. 
Number of Asbestos fibre size Epithelioid N, % Biphasic N, % Sarcomatous N, % Total P-value^ 
Crocidolite 1-5 µm 
0  104 (61.5) 40 (65.6) 23 (71.9) 167 (63.7) 0.642 
1 - 999 999 52 (30.8) 20 (32.8) 9 (28.1) 81 (30.9)  
1 000 000 - 2 999 999 6 (3.6) 1 (1.6) 0 (0.0) 7 (2.7)  
≥3 000 000  7 (4.1) 0 (0.0) 0 (0.0) 7 (2.7)  
Crocidolite >5-10 µm      
0  86 (50.9) 35 (57.4) 18 (56.3) 139 (53.1) 0.458 
1 - 999 999  64 (37.9) 24 (39.3) 13 (40.6) 101 (38.6)  
1 000 000 - 2 999 999  9 (5.3) 2 (3.3) 1 (3.1) 12 (4.6)  
≥3 000 000  10 (5.9) 0 (0.0) 0 (0.0) 10 (3.8)  
Crocidolite >10 µm      
0  93 (55.0) 33 (54.1) 19 (59.4) 145 (55.3) 0.836 
1 - 999 999 60 (35.5) 25 (41.0) 11 (34.4) 96 (36.6)  
1 000 000 - 2 999 999  10 (5.9) 3 (4.9) 2 (6.3) 15 (5.7)  
≥3 000 000  6 (3.6) 0 (0.0) 0 (0.0) 6 (2.3)  
Amosite 1-5 µm 
0  162 (95.9) 59 (96.7) 32 (100.0) 253 (96.6) 0.675 
1 - 999 999 6 (3.6) 1 (1.6) 0 (0.0) 7 (2.7)  
1 000 000 - 2 999 999  1 (0.6) 1 (1.6) 0 (0.0) 2 (0.8)  
≥3 000 000  0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)  
Amosite >5-10 µm 
0  159 (94.1) 58 (95.1) 30 (93.8) 247 (94.3) 0.749 
1 - 999 999  9 (5.3) 2 (3.3) 2 (6.3) 13 (5.0)  
1 000 000 - 2 999 999  1 (0.6) 1 (1.6) 0 (0.0) 2 (0.8)  
≥3 000 000  0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)  
Amosite > 10µm 
0  160 (94.7) 57 (93.4) 29 (90.6) 246 (93.9) 0.343 
1 - 999 999 9 (5.3) 3 (4.9) 3 (9.4) 15 (5.7)  
1 000 000 - 2 999 999  0 (0.0) 1 (1.6) 0 (0.0) 1 (0.4)  
≥3 000 000  0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)  
Chrysotile 1-5 µm      
0  169 (100.0) 61 (100.0) 32 (100.0) 262 (100.0) - 
1 - 999 999 - - - -  
1 000 000 - 2 999 999  - - - -  
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≥3 000 000  - - - -  
Chrysotile >5-10 µm      
0  169 (100.0)       61 (100.0)          32 (100.0)       262 (100.0)        
1 - 999 999 - - - -  
1 000 000 - 2 999 999  - - - -  
≥3 000 000  - - - -  
Chrysotile >10 µm      
0  168 (99.4)       61 (100.0)          32 (100.0)       261 (99.6)       1.000 
1 - 999 999 1 (0.6) 0 (0.0) 0 (0.0) 1 (0.4)  
1 000 000 - 2 999 999       
≥3 000 000       
^ Fischer’s exact test was conducted 
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CHAPTER FOUR – DISCUSSION  
 
4.1 Discussion 
 
The aim of this study was to describe data collected on individuals 
diagnosed with mesothelioma at the NIOH from 2006 to 2016. This was 
achieved by describing and comparing the environmental and 
occupational cases of mesothelioma in terms of demographic 
characteristics, ART/KRT compensation outcomes and the asbestos fibre 
burden. The associations between mesothelioma subtypes and asbestos 
types, burden and fibre sizes were also analysed.  
 
Of the cases diagnosed with mesothelioma in the PATHAUT database 
over the 11-year study period, there were more occupational than 
environmental mesothelioma cases. In the occupational setting, more than 
80% of the cases were male. McCulloch (2003) described that even 
though women comprised up to half of the South African asbestos mine 
workforce, they were invisible in the industry as women were never 
formally employed in asbestos mines. This could explain why so few 
women were identified in this study, especially in the occupational setting.  
 
In the environmental setting more than 60% of cases were seen in 
women. The overall male to female ratio for occupational cases was 7:1, 
while the overall female to male ratio for environmental cases was 3:1. 
These findings agree with the study by Haber & Haber (2011) that found a 
higher male to female ratio among occupational cases and a higher 
female to male ratio among non-occupational cases. These findings were 
also in agreement with reports from other South African studies which also 
found that females with mesothelioma predominate in the environmental 
setting (Nelson & teWater Naude, 2016; Phillips et al., 2012). The 
predominance of females in the environmental setting could be as a result 
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of domestic exposure to asbestos containing dust at home or in the 
neighbourhood. 
 
We found that the mean age of individuals who had mesothelioma was 
about 64 years and the peak prevalence of mesothelioma among our 
study population was 50-59 years. Our result was in agreement with the 
findings of a global study by Delgermaa et al that reported a mean age of 
63.4 years among mesothelioma patients in South Africa (Delgermaa et 
al., 2011). However, Delgermaa and colleagues reported a higher global 
mean age of mesothelioma deaths of 70.1 years.  (Delgermaa et al., 
2011). Delgermaa and colleagues ascribed the lower mean age of 
mesothelioma cases in South Africa to a background lower life expectancy 
as compared to the life expectancy indices in high income countries.  
Likewise, Kielkowski and colleagues suggested that the lower mean age 
of South Africa’s mesothelioma cases can be attributed to competing 
causes of death, as fewer people reach the age at which clinical 
symptoms of the disease manifest (Kielkowski et al., 2011). 
 
Although mesothelioma is described as a disease of the elderly (Thomas 
et al., 2015), younger patients have also developed the disease. Our study 
found that the youngest mesothelioma case was 40 years old.  However, 
younger mesothelioma cases were also reported elsewhere by Perez-
Guzman and colleagues (2016) who documented malignant pleural 
mesothelioma in a 17-year-old boy in Mexico. The higher risk of 
diagnosing mesothelioma among young adults in South Africa may be 
partly related to the common practice of early exposure when children play 
on asbestos waste dumps or used these dumps as sandpits (Braun and 
Kisting (2006). Being environmentally exposed at such a young age would 
lead to the disease developing earlier in life. For occupational cases, the 
overall mean age was 64.0 years. The overall mean age for environmental 
cases was 64.3 years. The mean age for males was 60.6 years and for 
females 65.3 years. No statistical differences were found between the 
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mean ages of males and females or between ages in the occupational and 
environmental setting. 
 
More than half of the cases in this study, (both occupational and 
environmental), came from the Northern Cape Province. Although Muteba 
(Muteba 2018) showed that Gauteng province had the highest 
mesothelioma cases and deaths as respectively reported by the National 
Cancer Registry (NCR) and Statistics South Africa (Stats SA), the majority 
of ART/KRT cases came from the Northern Cape province. The majority of 
crocidolite asbestos was mined and milled in the Northern Cape Province 
along the asbestos belt where small operations and larger companies 
mined Cape Crocidolite asbestos (van Zyl, 2017).  The high prevalence of 
environmental cases of mesothelioma also confirmed the environmental 
contamination in the Northern Cape Province caused by big operations, 
such as mines operated by GEFCO, Gencor and small independent mines 
on farms (van Zyl, 2017). Our findings show a provincial disparity of 
mesothelioma cases as compared to Stats SA and NCR. This suggests 
that mesothelioma sufferers (who are likely to be staff of asbestos mining 
companies) and their families in the Northern Cape usually prioritise 
reporting to the PATHAUT or other Trusts (ART/KRT) because of the 
financial benefits that may ensue. 
 
Almost a third of the miners in the study worked for GEFCO mines. Others 
worked in asbestos mines such as Cape Blue, Pomfret and Gencor. This 
may suggest that GEFCO mines were the predominant company. Around 
4% of our study population of mesothelioma cases were employed at Iscor 
corporation. Ordinarily, the staff of Iscor were not expected to be 
occupationally exposed to asbestos However, the boilers and pipes that 
were utilised by Iscor for the majority of their operations were covered in 
asbestos lagging to retain heat. The lagging consisted of long asbestos 
fibres woven as a fabric (NEDLAC, 2002). This may have resulted in 
exposure to asbestos for Iscor workers. 
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Looking at service years, there was an increase in mesothelioma cases 
from 16% to 35% amongst those who began service between the years 
1970 to 1979, a period when South African asbestos production was at its 
peak of 350 000 tons per annum (Kielkowski et al., 2011; Virta, 2006). 
This possibly reflects high exposures due to high production.  
 
Of the cases that applied for compensation through the ART/KRT, more 
than 85% were compensated.  Our study further showed that about one- 
third of the unsuccessful claims were environmentally related. The 
concern regarding compensation for environmental asbestos-related 
diseases was previously addressed by Ndlovu and colleagues (2013). 
They concluded that exposure to asbestos outside of the workplace 
contributed to asbestos-related diseases and that most future asbestos-
related diseases will be as a result of neighbourhood exposures in South 
Africa. The other two thirds of unsuccessful claimants were working for 
non-compensable operations, such as Iscor and Eskom but will still be 
able to apply for compensation under the statutory compensation acts. 
The rest might not have been compensated as they did not meet some of 
the criteria required by the ART/KRT. 
 
To assist the compensation process in terms of the ODMW Act, cardio-
respiratory organs are examined by pathologists who utilize 
histopathological techniques to make the diagnosis of malignant 
mesothelioma. Thereafter, the pathologist request samples of the lung to 
be sent to the EM department for asbestos fibre count analysis. Fibre 
count analysis was performed on more than 95% of all cases in this study. 
The remainder were either not sent for analysis or not entered into the EM 
database.   
 
Asbestos fibre analysis showed crocidolite was present in more than half 
(53.4%) of the lungs. Only one case contained chrysotile fibres and these 
were found together with amosite fibres. No cases were reported where 
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only chrysotile fibres were present in the lungs. These findings are in 
keeping with a study by Nolan and colleagues (2006) who found that most 
cases contained crocidolite, and chrysotile was never found alone. Studies 
showed that chrysotile is cleared by macrophages from the lungs even 
though it may still cause damage to the lungs (Landrigan et al., 1999; 
Martinez-Alier, 2001; Gibbs et al., 1998). A more recent study by Bernstein 
and colleagues (2015) also showed that chrysotile is cleared from lungs 
which would explain why so few chrysotile fibres were found when 
performing the fibre analysis.  
 
Overall, fibre analyses revealed that occupational mesothelioma cases 
contained higher concentration of asbestos fibres and bodies compared to 
environmental cases. This was anticipated as higher exposures were 
expected for occupational cases. Asbestos bodies are normally associated 
with high asbestos exposure. In mesothelioma, asbestos bodies can also 
be histologically present (Wolff et al., 2015). 
 
The epithelioid subtype of mesothelioma was the predominant histological 
type with a prevalence of 64.4% among the mesothelioma cases. 
Furthermore, the epithelioid subtype was also a major histological subtype 
among both occupational (63.9%) and environmental (69.0%) cases. This 
histological pattern that was observed among our study population is 
similar to the findings of Haber & Haber 2011, Franklin et al., 2016 and 
Brcic & Kern 2020 who found that epithelioid histological type was the 
major subtype of mesothelioma. Only three female cases (9.1%) were 
diagnosed with the sarcomatous subtype compared to 20.6% and 19.0% 
for biphasic and epithelioid, respectively. A study by Klebe and colleagues 
(2010) had similar findings where only 4% of female cases were 
diagnosed with the sarcomatous subtype of mesothelioma.  
 
Our study demonstrated that on the average, individuals with the 
sarcomatous subtype appeared to be about five years older at diagnosis 
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than individuals diagnosed with the other two histological subtypes.  
Similarly, Franklin and colleagues (2016), showed that patients diagnosed 
with sarcomatous mesothelioma were slightly older at diagnosis, thereby 
suggesting a longer latency period. Haber & Haber (2011) found a 
significant difference between the survival periods when comparing the 
epithelioid and sarcomatous subtype. The mean survival period for the 
epithelioid type was 12.2 months versus 7.3 months for the sarcomatous 
subtype.  
 
Expectedly, we found that the concentration of asbestos fibres was 
generally higher among the occupational cases of mesothelioma as 
compared to the environmental cases. The most commonly identified fibre 
in the lung (occupational and environmental cases) was crocidolite.  
However, there was no statistically significant difference of the asbestos 
fibres across the mesothelioma subtype. This finding is similar to the 
report by Franklin and colleagues (2016).  In contrast, Klebe and 
colleagues (2010) observed that the lungs of sarcomatous cases 
contained more amosite fibres.  Thus, exposure to crocidolite is a major 
risk factor for the evolution of mesothelioma in South Africa, (even among 
the environmentally exposed cases) (Nolan et al., 2006). 
 
We found that there was no statistically significant relationship between 
mesothelioma subtype, asbestos types, burden and fibre sizes. Franklin 
and colleagues (2016) also found no association between mesothelioma 
subtypes and asbestos exposure characteristics. However, the 
conclusions by Franklin and co-workers may not be valid as fibre analysis 
was only performed on 7% (122/1656) of their study population. 
Additionally, Franklin et al stated that it was difficult to investigate the 
different fibre types as their mixed fibre exposure group were likely to have 
had some crocidolite exposure. The study concluded that the possibility 
that fibre type affects the development of a particular mesothelioma 
subtype remains unknown (Franklin et al., 2016). Likewise, Haber & Haber 
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(2011) also found that the intensity of exposure and exposure frequency 
does not influence the development of the mesothelioma subtype. 
However, Klebe and colleagues (2010) found a significantly higher 
amosite concentration in sarcomatous subtypes. 
 
51  
  
4.2 Limitation of the study 
 
Some limitations of this study are related to secondary data analysis, as 
routinely collected administrative databases that were created primarily for 
compensation purposes were utilised. These databases had incomplete 
records such as occupational histories and other demographic information 
that may impact on the study conclusions.   
 
The PATHAUT database provides data on ex-miners or workers that 
worked at a controlled mine or works. The data, therefore, were primarily 
of workers that were occupationally exposed. Environmental cases were 
only recorded if the ART/KRT sent such cases to the NIOH. The ART/KRT 
were the only Trusts that provides compensation for environmental cases 
of asbestos-related disease. However, to qualify for compensation from 
the Trusts, environmental cases must fulfil certain criteria. Not all cases of 
mesothelioma fulfil these criteria and will therefore not be eligible for 
compensation nor autopsy at the NIOH.   
 
PATHAUT data only captured individuals who had an autopsy-confirmed 
diagnosis of Mesothelioma. However, there are several barriers to 
requesting and providing consent for autopsy by relations of deceased 
miners. (Mthombeni 2017). Ignorance, distrust of the compensation 
system, traditions and religious beliefs and poor access to an autopsy 
facilities were some identified barriers to autopsy of potential 
mesothelioma cases. (Mthombeni 2017). Moreover, racial and regional 
disparity also impact on request and consent for autopsy. Invariably, the 
incidence of mesothelioma in South Africa is under-reported by the 
PATHAUT register. (Ndlovu et al., 2017).  
 
Cases that were diagnosed with asbestosis or pleural plaques could have 
served as a comparison group to improve the validity of our findings and 
conclusions. Additionally, fibre burden analyses may not reflect true 
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exposure to chrysotile asbestos as chrysotile fibres can be cleared from 
the lung, thereby leading to lower concentrations of fibres found in the lung 
at autopsy. 
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CHAPTER FIVE – CONCLUSION AND RECOMMENDATION 
 
5.1 Conclusion  
 
No strong evidence was found to support any relationship between 
mesothelioma subtype and asbestos type, fibre size or asbestos burden. 
However, there was a statistically significant difference in mean age 
between the sarcomatous and biphasic subtype and between the 
sarcomatous and epithelioid subtype. 
 
This study supports the mesotheliomagenic potential fibre gradient for 
South Africa as crocidolite> amosite> chrysotile. Although South Africa 
mined crocidolite, amosite and chrysotile on a commercial scale, 
crocidolite is the main cause of mesothelioma in South Africa. 
 
Mesothelioma subtypes have different characteristics, prognoses and 
outcomes. The aetiology and evolution of these subtypes remain 
unknown. Research to further characterise aetiopathology of these 
histological subtypes is necessary. 
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5.2 Recommendations 
 
Not all cases in the PATHAUT database could be linked to the EM 
database. Stricter quality control regarding samples sent for fibre analysis 
and stricter quality controls for the EM database is recommended. 
Capturing all information collected and validation of data is critically 
important for reliable and accurate results. 
 
Further research is needed to validate the findings of this study and to 
further explore the development of the different subtypes of mesothelioma. 
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APPENDICES 
 
APPENDIX A – Extraction of Asbestos Fibres from Lung Tissue 
 
A Pathologist examines the lungs of deceased individuals and sends 
representative samples of all lobes of the diseased lungs in formalin to the 
EM Unit. The sample is recorded in a register with a unique number and 
job cards are created which includes the SEM and LM counting sheets, 
the SEM and LM findings sheets, and supporting pictures for the SEM 
analysis.  
A competent laboratory staff member (technician, technologist or scientist) 
prepares the sample in terms of three weights that are required to 
calculate the number of asbestos fibres in the whole lung by only using a 
smaller representative part of the lung. The three weights are digested 
reference weight, the wet reference tissue weight and the dry reference 
tissue weight (all nett weights).  
 
To obtain the digested reference weight, a representative sample (6 – 10 
grams) is placed in a foil basket and the nett weight of the sample is 
calculated. After this, the sample is digested with potassium hydroxide, 
centrifuged and the supernatant is discarded. The remaining fluid is placed 
in a crucible and ashed in a furnace. Hydrochloric acid is used to help 
remove the remains from the crucible. The fluid sample is placed in a 
falcon and diluted with distilled water. Thereafter, the sample fluid is 
pushed through a gold-coated filter (0,2 µm) and left to dry. This sample is 
prepared for SEM. The sample fluid is also pushed through another filter 
(0,45 µm) and left to dry. This sample is for LM analysis. The 0,2 µm filter 
is then placed on a sticky carbon planchet and coated with gold. The 0,45 
µm filter is placed on a glass slide, cleared with acetone and coverslipped. 
 
The wet reference weight is obtained by placing a representative lung 
sample (6 – 10 grams) in a foil basket and calculating the nett weight. This 
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sample foil basket is placed in an incubator for the lung to dry. The dry 
reference weights are then also calculated by weighing the lung once it is 
dry. 
 
The number of fibres on the 0,2 µm filter is counted using an SEM at 2000 
times magnification and counting 200 fields on each filter. This method is 
in accordance with the Asbestos International Association’s recommended 
technical method (RTM-2) for counting asbestos fibres. A fibre is regarded 
as anything with a ratio of 3:1. All fibres are analysed using electron 
dispersive spectroscopy (EDS) to determine if they are asbestos fibres.  
 
The different types of asbestos have different chemical compositions and 
the EDS can determine this. Chrysotile is composed of magnesium and 
silica and this will display as peaks on the EDS graph in an equal ratio with 
the magnesium peak being slightly higher than that of the silica. 
Crocidolite will display peaks in different ratios with silica being the highest 
followed by sodium, iron and magnesium. Amosite displays peaks of silica, 
magnesium and iron. In this way, asbestos fibre types can be determined. 
Examples of EDS graphs are displayed below. 
 
Chrysotile 
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Crocidolite 
 
Amosite 
 
 
The 0,45 µm filter is counted by using a phase microscope. Counting is 
done with a 40 x objective is in place and the 12.5 x eyepiece at a total of 
500 x magnification and counting 100 fields. This method is in accordance 
with the Asbestos International Association’s recommended technical 
method (RTM-1) for counting asbestos fibres. This is only done as a 
quality assurance check to ensure the LM and SEM counts match. If 
discrepancies are picked up, such as fibres were seen on under the LM 
microscope and not under SEM, the sample will be pushed through the 
two filters again and reanalysed. Fibre and asbestos body counts are 
reported as the number of fibres per gram of dried lung tissue. 
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Data obtained from the SEM and LM analysis are entered into the EM 
database. The database was set up to automatically calculate the wet and 
dry fibre and asbestos body concentrations. The calculation for the total 
asbestos fibres per gram of dry lung tissue using SEM is as follow: 
Asbestos fibres/g tissue = (((total number of fibres counted/(0.0030672 x 
200)) x 380.13) / wet tissue weight) x (wet tissue weight/dry tissue weight) 
x 50 ml. 
 
Identifying asbestos is a skilled technique and requires a trained analyst. 
The NIOH participates in an External Quality assessment programme the 
Asbestos in Materials Scheme (AIMS) from the Health and Safety 
Laboratory (HSL) from the United Kingdom that enables them to correctly 
identify the different types of asbestos. 
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APPENDIX B – Variables used in each data set 
 
Pathaut 
database 
variables 
Pathaut 
variable 
description 
ART/KRT 
database 
variables 
ART/KRT 
variable 
description 
EM lung 
database 
variables 
EM variable 
description 
pnum 
Pathology 
number 
idnum2 
Identification 
number 
pno Pathology number 
idnum 
Identification 
number 
status 
Claim 
outcome 
Semtotdry 
Dry concentration of 
asbestos fibres 
counted 
year Year of death    Asbboddry 
Dry concentration of 
asbestos bodies 
counted 
Codpath 
1-3 
CoD by 
Pathology 
   Am5dry 
Dry concentration of 
amosite fibres 
counted 
pathdesc 
CoD 
description 
   
Am 
5_10dry 
Dry concentration of 
amosite fibres 
counted 
popcode Race    Am10dry 
Dry concentration of 
amosite fibres 
counted 
age Age at death    Croc5dry 
Dry concentration of 
crocidolite fibres 
counted 
O/E 
Occupational / 
environmental 
  
Croc 
5_10dry 
Dry concentration of 
crocidolite fibres 
counted 
exptype 
1-4 
From 
commodity 
most exposed 
to least 
   Croc10dry 
Dry concentration of 
crocidolite fibres 
counted 
expyear 
1-4 
Exposure 
years 
   Chry5dry 
Dry concentration of 
chrysotile fibres 
counted 
yearstar 
Year mining 
occupation 
started 
   
Chry 
5_10dry 
Dry concentration of 
chrysotile fibres 
counted 
yearend 
Year mining 
occupation 
ended 
   Chry10dry 
Dry concentration of 
chrysotile fibres 
counted 
lastmine 
Last mine 
case worked 
   Oth5dry 
Dry concentration of 
non-asbestos fibres 
counted 
milmeso Mesothelioma    
Oth 
5_10dry 
Dry concentration of 
non-asbestos fibres 
counted 
milmesep 
Epithelioid 
subtype 
   Oth10dry 
Dry concentration of 
non-asbestos fibres 
counted 
milmesar 
Sarcomatous 
subtype 
   Othspec 
Description of non-
asbestos fibres 
Meso 
Type 
Histological 
subtype 
    
gender Sex      
province SA province      
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APPENDIX C – NIOH Consent Form for a Post-Mortem Examination 
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APPENDIX D – Research Ethics Approval  
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APPENDIX E – Ethics Clearance from The Ethics Committee at Wits to 
Study Data Collected in The PATHAUT Database  
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APPENDIX F – Turnitin Report 
 
 
79  
  
 
 
